The medical technology company Synthetic MR reports lower revenue for the first quarter compared with the same period last year. The operating loss narrowed.Revenue fell 7.7 percent to SEK 13.1 million (14.2)."The decline is mainly explained by lower OEM sales in Europe and North America. In APAC, developments in Japan have been negatively affected by the prevailing economic situation, which has led to greater caution in investments," says CEO Lena Åredal. "At the same time, we continue to strengthen our operational efficiency. Our costs decreased by 16.5 percent compared with the corresponding period last year, mainly as a result of the cost-saving measures implemented at the beginning of 2025 and continued strong cost discipline in the business." The operating result was SEK -6.3 million (-10.2). Profit after tax was SEK -6.2 million (-13.3). Earnings per share amounted to SEK -0.08 (-0.35). Cash flow from operating activities amounted to SEK -3.6 million (1.8). Cash and cash equivalents amounted to SEK 32.9 million (22.7).Synthetic MR, SEK millionQ1-2026Q1-2025ChangeNet sales13.114.2-7.7%Operating result-6.3-10.2Net result-6.2-13.3Earnings per share, SEK-0.08-0.35Cash flow from operating activities-3.61.8Cash and cash equivalents32.922.744.9%